跳至主要内容
临床试验/NCT02977559
NCT02977559Unknown不适用

A Comparative Randomized Prospective Study Between the New Laryngeal Tube Suction-Disposable and the Ambu AuraGain in Pediatric Patients

Bnai Zion Medical Center0 个研究点目标入组 60 人开始时间: 2017年3月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
60
主要终点
Leak pressure measure in cm H2O

研究概览

简要总结

The study compared the Laryngeal Tube Suction Disposable (LTS-D) with the Disposable Laryngeal Mask Ambu® AuraGain™ (DLMA AG) during general anesthesia in pediatric patients.

The investigators hypothesized that the LTS-D and the DLMA AG performed similarly during mechanical ventilation despite differences in their structural design.

详细描述

The Laryngeal Tube Suction-Disposable (LTS-D, (VBM Medizintechnik GmbH, Sulz, Germany), is a second generation single-use supraglottic airway devices (SADs) with gastric access, for airway management in spontaneously and mechanically ventilated patients undergoing general anesthesia.

The AuraGain is a second generation laryngeal mask, satisfying airway management needs by integrating gastric access and ventilation capability in an anatomically curved single-use device that facilitates rapid establishment of a safe airway.

The two devices have now pediatric sizes.

To date, there is no published data comparing the LTS-D and the DLMA AG during mechanical ventilation in pediatric patients. The investigators hypothesized that the LTS-D and the DLMA AG perform similarly during mechanical ventilation despite differences in their structural design.

The chief aim of this prospective randomized study was to compare the LTS-D and the DLMA AG with respect to:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
1 Year 至 10 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Pediatric patients, American Society of Anesthesiologist (ASA) physical status I and II weighing 30 to 10 kg, posted for abdominal surgery under general anesthesia.

排除标准

  • Infants with active respiratory tract infection anticipated and known difficult airway, lung disease requiring high positive end expiratory pressure, and active gastrointestinal reflux will be excluded.

研究组 & 干预措施

Laryngeal Tube Suction Disposable

Experimental

Laryngeal Tube Suction Disposable for ventilation

干预措施: Laryngeal Tube Suction Disposable (Device)

Laryngeal Mask Airway AuraGain

Experimental

Laryngeal Mask Airway AuraGain for oxygenation and ventilation

干预措施: Laryngeal Mask Airway AuraGain (Device)

结局指标

主要结局

Leak pressure measure in cm H2O

时间窗: 60 seconds

次要结局

  • Time to insertion a device in seconds(60 seconds)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

LUIS.GAITINI

medical doctor

Bnai Zion Medical Center

相似试验